Rhône-Poulenc Rorer Inc. sales and marketing update

RPR began selling Taxotere (docetaxel) in Australia, Austria, Brazil, Denmark, Germany, the Netherlands, Norway and Uruguay. The product is approved to treat advanced breast cancer and non-small cell...